Loading data for HELX — first visit, this takes a few seconds.
Franklin Genomic Advancements ETF (HELX)
Cboe US: HELX
· Real-Time Price · USD
41.95
-1.56 (-3.59%)
At close: Sep 01, 2026, 6:09 PM
Franklin Genomic Advancements ETF (HELX) ETF Price, Holdings & Analysis
| Bid | 20.45 |
| Market Cap | n/a |
| AUM | 29.1M |
| NAV | 42.06 |
| Beta | 0.99 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 35.40 |
| Shares Out | n/a |
| Inception Date | Feb 25, 2020 |
| Ask | 86.11 |
| Volume | 2,277 |
| Avg. Volume (20D) | 2,552 |
| Open | 43.06 |
| Previous Close | 43.51 |
| Day's Range | 42.08 - 43.06 |
| 52-Week Range | 29.80 - 43.51 |
| Holdings | n/a |
| Expense Ratio | 0.50% |
About HELX
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Asset Class Equity
Ticker Symbol HELX
Inception Date Feb 25, 2020
Provider Franklin Templeton Investments
Website Fund Home Page
Exchange Cboe US
Top 10 Holdings 47.90% of assets
| Name | Symbol | Weight |
|---|---|---|
| Guardant Health Inc | GH | 10.09% |
| Natera Inc | NTRA | 7.57% |
| Krystal Biotech Inc | KRYS | 5.97% |
| Ligand Pharmaceutica... | LGND | 4.32% |
| Adaptive Biotechnolo... | ADPT | 4.32% |
| Bridgebio Pharma Inc | BBIO | 3.87% |
| United Therapeutics ... | UTHR | 3.45% |
| Eli Lilly And Co | LLY | 2.91% |
| Vertex Pharmaceutica... | VRTX | 2.71% |
| Samsung Biologics Co... | 207940.KQ | 2.69% |
Dividends Dividend Yield 0.34%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 30, 2025 | $0.1430 | n/a |
| Dec 30, 2021 | $0.0040 | n/a |
| Dec 13, 2021 | $0.1140 | n/a |
| Dec 14, 2020 | $0.0520 | n/a |
